Based in St Vincent and the Grenadines, Headland is life sciences and biotechnology platform built to ethically harness the healing power of psychedelics, fungi, and medicinal plants. We develop medicines deemed effective in improving mental health, limiting substance abuse, and treating brain injury.

Headland’s licenses enable its scientists to leverage the most comprehensive portfolio of plant-based protocols available globally in the company’s quest to become a Caribbean leader in plant-based medicinal wellness - from cultivation to clinics.

The Platform is focused on 3 specific areas:

• Research & Development: Headland’s R&D efforts are dedicated to conducting clinical trials and creating I.P. from research centred around Phytochemical discovery and Mycology

• Natural Health & Wellness Products: Headland will refine entheogens and other medicinal plants to manufacture a portfolio of natural health products and plant-derived pharmaceuticals for individuals seeking both medicinal or pharmaceutical remedies and general wellness.

• Therapeutic Treatment and Clinics: Headland's therapeutic practice partners with high-pedigree clinical brands to provide best-in-class therapeutic offerings to aid patients experiencing trauma, depression, PTSD, and addiction.